ProfileGDS4718 / 202543_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 95% 77% 96% 97% 91% 91% 95% 94% 96% 97% 95% 95% 89% 95% 94% 93% 96% 89% 90% 96% 95% 96% 96% 97% 93% 91% 86% 95% 91% 93% 94% 94% 97% 93% 90% 94% 92% 93% 62% 96% 91% 92% 96% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.979997
GSM549102patient 115, normal, homogenized [OPG study]10.377995
GSM549104patient 119, normal, homogenized [OPG study]7.6414677
GSM549108patient 138, normal, homogenized [OPG study]10.467796
GSM549119patient 077, normal, homogenized [OPG study]11.047697
GSM549133patient 032, cancer, homogenized [OPG study]9.4523491
GSM549139patient 042, cancer, homogenized [OPG study]9.415791
GSM549099patient 107, normal, homogenized [OPG study]10.24995
GSM549109patient 139, normal, homogenized [OPG study]9.9772694
GSM549110patient 046, normal, homogenized [OPG study]10.632496
GSM549114patient 063, normal, homogenized [OPG study]11.053397
GSM549122patient 082, normal, homogenized [OPG study]10.170495
GSM549134patient 033, cancer, homogenized [OPG study]10.310895
GSM549136patient 036, cancer, homogenized [OPG study]9.1324789
GSM549140patient 044, cancer, homogenized [OPG study]10.09995
GSM549111patient 047, normal, homogenized [OPG study]10.101294
GSM549113patient 057, normal, homogenized [OPG study]10.064593
GSM549132patient 031, cancer, homogenized [OPG study]10.37696
GSM549137patient 038, cancer, homogenized [OPG study]9.0595589
GSM549142patient 047, cancer, homogenized [OPG study]8.6657490
GSM549100patient 110, normal, homogenized [OPG study]10.530596
GSM549107patient 135, normal, homogenized [OPG study]10.431995
GSM549115patient 068, normal, homogenized [OPG study]10.736596
GSM549116patient 072, normal, homogenized [OPG study]10.684696
GSM549120patient 078, normal, homogenized [OPG study]11.014197
GSM549131patient 030, cancer, homogenized [OPG study]9.7775793
GSM549118patient 074, normal, homogenized [OPG study]9.5152891
GSM549129patient 027, cancer, homogenized [OPG study]8.50786
GSM549123patient 088, normal, homogenized [OPG study]10.359895
GSM549124patient 006, cancer, homogenized [OPG study]9.1618391
GSM549126patient 015, cancer, homogenized [OPG study]9.7402393
GSM549128patient 025, cancer, homogenized [OPG study]9.9889194
GSM549103patient 117, normal, homogenized [OPG study]9.9510994
GSM549117patient 073, normal, homogenized [OPG study]11.119197
GSM549138patient 041, cancer, homogenized [OPG study]9.6715993
GSM549141patient 045, cancer, homogenized [OPG study]9.1929990
GSM549130patient 028, cancer, homogenized [OPG study]9.7993994
GSM549101patient 111, normal, homogenized [OPG study]9.539392
GSM549105patient 128, normal, homogenized [OPG study]9.8230693
GSM549106patient 134, normal, homogenized [OPG study]6.2701862
GSM549112patient 048, normal, homogenized [OPG study]10.639996
GSM549125patient 011, cancer, homogenized [OPG study]9.224591
GSM549127patient 024, cancer, homogenized [OPG study]9.4718492
GSM549135patient 035, cancer, homogenized [OPG study]10.608896